From multi-omics approaches to personalized medicine in myocardial infarction

C Zhan, T Tang, E Wu, Y Zhang, M He, R Wu… - Frontiers in …, 2023 - frontiersin.org
Myocardial infarction (MI) is a prevalent cardiovascular disease characterized by myocardial
necrosis resulting from coronary artery ischemia and hypoxia, which can lead to severe …

The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine

V Nakhonsri, S John, H Panumasmontol… - The Application of …, 2024 - Taylor & Francis
Introduction CYP2C19 plays a major role in the metabolism of various drugs. The most
common genetic variants were the CYP2C19* 2 and* 3 alleles (rs4244285 and rs4986893 …

[图书][B] Pharmacogenomics and Pharmacogenetics in Drug Therapy

M Khullar, A Mittal, A Patil, R Pignatello - 2024 - books.google.com
The genetic makeup of a person has been found to influence their response to several
drugs. Pharmacogenetics and pharmacogenomics provide useful information in this respect …

[HTML][HTML] Pharmacogenomics of Cardiovascular Diseases: The Path to Precision Therapy

G Nemer, NN Hendi - 2023 - intechopen.com
Cardiovascular diseases (CVD) represent a substantial global health burden, leading to
significant morbidity and mortality rates. However, the efficacy and safety of CVD therapies …